18 May 2021
RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension
Sponsored by ReCor Medical
Speaker:
A. Sharp
Summary
Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering effectiveness at two months).
View the recording of this EuroPCR 2021 Session on "A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort".
Learning Objectives
- To learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system
- To hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering effectiveness at two months)